consequently, this may represent a potential concern during GLP-1 RA-based obesity interventions
Interestingly, studies examining placental passage of exenatide and liraglutide in human cases suggest minimal to no fetal exposure shortly after administration, indicating that maternal metabolic effects, rather than direct fetal exposure, may contribute to adverse outcomes
Additionally, most studies were observational in nature, limiting the ability to establish causality
For a 30mg vial, adding 3mL gives 10mg/mL
"Analgesic-antipyretic and Antiinflammatory Agents and Drugs Employed in the Treatment of Gout" in, "Goodman & Gilman's The Pharmacological Basis of Therapeutics 10th Edition" by Hardman, J.G
A Zepbound for weight loss injection activates brain receptors, managing hunger and enhancing feelings of fullness, resulting in fewer cravings